Breast Cancer News, page-3

First 3 Last

Share
Profile

Follow
Japes

863 Posts.

32

03/10/14

09:52

Post #: 14069390
Share

Originally posted by inv2013 ↑

See full report here

"In the press release of Aug 1st, 2014 the Company reported successful silencing of the IDO gene in human dendritic cells (DC) treated with newly developed proprietary gene-silencing technology which was in part licensed from Benitec Biopharma. Today the Company reports that dCellVax generated according to the protocols that will be submitted to the FDA was capable of potently stimulating human T cells to kill breast cancer cells. Combined with animal model efficacy data, GMP-grade manufacturing protocols, and animal safety data, the Company believes it has completed the necessary experimental work to begin writing its IND for a proposed clinical trial in breast cancer patients."

"Immunotherapy offers the possibility of killing tumors by harnessing the power of the immune system. This type of treatment generally lacks the toxicity associated with chemotherapy or radiotherapy and is capable of killing metastatic cells, which usually cause relapse in cancer patients. dCellVax is an immunotherapy using DC generated from breast cancer patients which have been modified so as to lack an enzyme, indolamine 2,3 deoxygenase (IDO) that inhibits the immune response. By lacking this enzyme, the modified DC become potent stimulators of the immune system, a finding which was confirmed by the experiments completed today"

Expand

Thanks INV...,
Max has some background on Thomas Ichim, their CSO. He maybe sold his company to Regen. At the time his board included some big money. He was also involved in R&D with Benitec, before selling out.
just a bit of fluff stuff from me, but he used to sound pretty switched on.

BLT Price at posting: 99.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

OSL

Oncosil device successfully treats pancreatic cancer in Türkiye

MXR

Maximus picks up 25.93 g/t of gold through infill drilling at WA's Hilditch

Emerald & Azure score Digger & Dealer awards

Earnings Wrap: why is the utilities sector tanking & other big name earnings on Thursday

Bitcoin: Current State of Play & Where to Next | Swyftx